4/A

FORM 4/A SUBMISSION

Company: Aldeyra Therapeutics, Inc.
Filed: May 5, 2016
Period of Report: March 16, 2016
Accession Number: 0000899243-16-019280

View Document ↗ View on SEC.gov ↗